The Beckley Foundation and its founder and long-time psychedelics researcher Amanda Feilding announced a new research program involving a pioneering study with King's College London and UCL on the ...
People with generalized anxiety disorder improved significantly after they got a single dose of LSD powerful enough to induce ...
Beginning in the 1950s, researchers published a flurry of papers exploring LSD's therapeutic uses, though most of them don't meet modern standards. “I see this paper as a clear step in the direction ...
A new study explores how LSD could influence the way the brain processes pain, breaking new ground for research The results revealed significant differences in how the brain processed pain under the ...
Tom Nolan, clinical editor; sessional GP, Surrey The BMJ , London Tom Nolan reviews this week’s research Aspirin and ...
The Beckley Foundation and its founder Amanda Feilding announced a new research program with King's College London and UCL on the effects of full dose LSD as well as a breakthrough study with the ...
LSD usage is on the rise among U.S. adults – especially young adults with depression. And the trend mirrors growing research into the psychedelic drug's ability to treat mental health disorders like ...
A clinical trial’s encouraging results won US Food and Drug Administration breakthrough therapy status for an LSD formulation to treat generalized anxiety disorder, Mind Medicine Inc. announced ...
The U.S. Food and Drug Administration (FDA) has granted breakthrough therapy status to an LSD formula to treat generalized anxiety disorder after an initial study has shown that a single dose of the ...
CLEVELAND, Ohio — The Cleveland Clinic is in the vanguard of a new era of research into psychedelic medicine. The Clinic is the only Ohio site participating in a national study looking at whether LSD, ...
MyTwinTiers.com on MSN
NYS Assemblymembers hold legislative hearing on psilocybin
A New York State legislative hearing was held this week in New York City about the medicinal value of psilocybin— a compound in psychedelic mushrooms. “When I first heard about it, I thought of LSD— a ...
For a couple of freewheeling years, two young Harvard psychologists have carried on wide-ranging experiments with mind-altering drugs. At the university’s Center for Research in Personality, they sent ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results